XERS SBC to Revenue

Xeris Biopharma Holdings Inc · SBC to Revenue

XERS logo

XERS SBC to Revenue

Current (TTM)8.38%
XERS SBC/Revenue (50.23% → 8.38%)
High-resolution chart · PNG

XERS sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
7.6637%
9.0427%
6.5376%
11.0297%
22.9502%
40.4845%
238.2072%
70.1014%
32.0694%
50.2326%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.